{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014858","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.882390+00:00","generated_at":"2026-05-19T10:41:53.066209+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Hepion shareholders reject reverse stock split amendment at 2025 annual meeting","bullets":["Reverse stock split proposal (1:5 to 1:20) failed with 2.25M for, 3.70M against; not approved.","All four director nominees (Brancaccio, Block, Lbiati, Purcell) elected despite majority of votes withheld.","Ratification of Grassi & Co. as auditors passed with 4.76M for vs 1.17M against.","Advisory say-on-pay failed with 162K for, 337K against.","Only 10.9M shares outstanding; broker non-votes totaled 5.46M on most proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014858","json":"https://secwatch.observer/filing/0001641172-25-014858.json","markdown":"https://secwatch.observer/filing/0001641172-25-014858.md","text":"https://secwatch.observer/filing/0001641172-25-014858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225014858/0001641172-25-014858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225014858/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:41:53.066209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}